FDA Inspection 1217487 — Rostein, Daniel MD SC
The FDA completed an inspection of Rostein, Daniel MD SC on Sep 11, 2023 in Oak Brook, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 11, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Oak Brook, IL (United States)